Introduction: The cannabinoids nabilone (Cesamet) and dronabinol (Marinol) are indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in cancer patients who have failed to respond adequately to conventional antiemetic therapy.
Discussion: The endocannabinoid (CB) system interacts with numerous other systems and pharmaceutical cannabinoids target ubiquitous CB1 and CB2 receptors in the central nervous system and periphery, relieving nausea and vomiting and pain.
Summary: The benefits of this novel class of medications in cancer may extend beyond CINV, as indicated by data from preclinical studies and animal models.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00520-006-0180-0 | DOI Listing |
Publication Analysis
Top Keywords
nausea vomiting
8
emerging role
4
role cannabinoid
4
cannabinoid neuromodulators
4
neuromodulators symptom
4
symptom management
4
management introduction
4
introduction cannabinoids
4
cannabinoids nabilone
4
nabilone cesamet
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!